首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Comparison of conventional radiotherapy and intensity-modulated radiotherapy for post-operative radiotherapy for primary extremity soft tissue sarcoma.
【24h】

Comparison of conventional radiotherapy and intensity-modulated radiotherapy for post-operative radiotherapy for primary extremity soft tissue sarcoma.

机译:常规放疗与调强放疗对原发性四肢软组织肉瘤术后放疗的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Doses in conventional radiotherapy for extremity soft tissue sarcoma (STS) potentially exceed normal tissue tolerances. This study compares 3D-conformal radiotherapy (3D-CRT) with intensity-modulated radiotherapy (IMRT) in optimising target volume coverage and minimising integral dose to organs-at-risk (OAR). METHODS AND MATERIALS: Ten patients undergoing post-operative radiotherapy for extremity STS were assessed. PTV(1) was defined as tumour bed plus 5cm superiorly/inferiorly and 3cm circumferentially, PTV(2) was defined as 2cm isotropically. OAR were defined as whole femur, neurovascular bundle, tissue corridor and normal tissue outside PTV(1). For each patient 2-phase 3D-CRT was compared to 2/3 field (2/3f) and 4/5 field (4/5f) IMRT with simultaneous integrated boost (SIB). The primary planning objective was to minimise femur and skin corridor dose. Volumetric analysis and conformity and heterogeneity indices were used for plan comparison. RESULTS: A planning protocol containing dose/volume constraints for target and OAR was defined. 4/5f IMRT showed greatest conformity and homogeneity. IMRT resulted in significantly lower femur V45 using 2/3f (p=0.01) and 4/5f (p=0.0009) than 3D-CRT. 4/5f IMRT resulted in significantly lower normal tissue V55 (p=0.004) and maximum dose (p=0.04) than 3D-CRT. CONCLUSIONS: A reproducible set of planning guidelines and dose-volume constraints for 3D-CRT and IMRT planning for extremity sarcomas was devised. 4/5f IMRT with SIB resulted in better target coverage and significantly decreased OAR dose. Further evaluation of this technique within a clinical trial is recommended to demonstrate that the technical benefit of the more complex technique translates into patient-derived benefit by reducing late toxicity.
机译:简介:传统放射疗法治疗肢体软组织肉瘤(STS)的剂量可能超过正常组织的耐受性。这项研究将3D适形放射疗法(3D-CRT)与强度调制放射疗法(IMRT)进行了比较,以优化目标体积覆盖率并最大程度地降低了对危险器官的剂量(OAR)。方法和材料:对十名接受过肢端STS放射治疗的患者进行了评估。 PTV(1)定义为肿瘤床加上上/下5cm,周长3cm,PTV(2)定义为各向同性2cm。 OAR被定义为整个PTV(1)之外的整个股骨,神经血管束,组织通道和正常组织。对于每位患者,将2相3D-CRT与2/3场(2 / 3f)和4/5场(4 / 5f)的IMRT进行了比较,同时具有集成的增强(SIB)。主要的计划目标是最大程度地减少股骨和皮肤走廊的剂量。容量分析以及整合和异质性指标用于计划比较。结果:制定了包含目标/ OAR剂量/体积约束的计划方案。 4 / 5f IMRT显示出最大的一致性和同质性。 IMRT使用2 / 3f(p = 0.01)和4 / 5f(p = 0.0009)导致股骨V45明显低于3D-CRT。 4 / 5f IMRT导致正常组织V55(p = 0.004)和最大剂量(p = 0.04)明显低于3D-CRT。结论:为3D-CRT和IMRT计划设计了一套可重现的规划指南和剂量体积约束,用于肢体肉瘤。具有SIB的4 / 5f IMRT可以实现更好的靶标覆盖范围,并显着降低OAR剂量。建议在临床试验中对该技术进行进一步评估,以证明更复杂技术的技术优势可通过减少后期毒性转化为患者带来的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号